Calcium supplements are a very useful way of helping individuals who are unable to consume sufficient calcium from dietary sources. An extra 500-700 mg elemental calcium per day will suffice for most people. The cheapest, easiest way to achieve this objective is with a single calcium carbonate tablet containing 600 mg elemental calcium.
Calcium carbonate contains 40% elemental calcium by weight compared with 21% in calcium citrate. Although calcium citrate is more soluble and its bioavailability may be approximately 25% greater than that of calcium carbonate3it is also more expensive. Calcium citrate was found to be less cost-effective than a calcium carbonate preparation in a recent study.4Clinical situations where calcium citrate may be preferred over calcium carbonate include achlorhydria (calcium carbonate requires an acid environment to dissolve, calcium citrate does not), and in patients who need calcium supplements but have a history of kidney stones (citrate in the urine inhibits calcium oxalate precipitation).5Calcium phosphate preparations have not been studied extensively, but appear to be absorbed adequately.6
In general, it is recommended to prescribe or advise the use of widely available, major brand-name calcium preparations whose absorbability has been well documented. This is because the absorbability of some marketed products is only 40-60% of that of plain calcium carbonate.
Administration
It is generally not important when calcium supplements are taken in relation to meals. Patients with achlorhydria appear to be an exception. Calcium carbonate is very poorly absorbed in these patients when fasting, but is absorbed satisfactorily when ingested with a meal.5There is some evidence that taking calcium supplements in the evening may be advantageous, by suppressing the nocturnal rise in bone resorption. It is critical that calcium and oral bisphosphonates are taken at least several hours apart as calcium binds with these medications and prevents their absorption.
Factors that impair the absorption of calcium supplements
Some dietary constituents can impair calcium bioavailability by forming insoluble calcium complexes.7These substances include phytates (found in cereals, bran, soybeans, seeds) and oxalates (found in spinach, rhubarb, walnuts). Some vegetarian diets may therefore adversely affect calcium balance, particularly if the calcium content is low due to the avoidance of dairy products.
Inadequate vitamin D nutrition is associated with impaired intestinal calcium absorption and must be corrected for ingested calcium to be effective. As the vitamin D content of our diet is generally low, people with low levels of sunlight exposure (the chronically-ill, housebound, people in residential care, some ethnic groups) are at high risk for vitamin D deficiency. Dark-skinned people, especially veiled women, are an important risk group. Their vitamin D status in pregnancy is a particular concern. Daily needs are probably of the order of 800 IU in these high-risk groups. This can be given as oral vitamin D2 1000 IU daily.
Long-term glucocorticoid treatment also causes calcium malabsorption. In general, when calcium supplements are recommended, vitamin D nutritional adequacy should be assured and other bone-protective interventions may be indicated. Renal impairment is associated with calcium malabsorption and this aspect of the care of patients with renal disease requires specialist advice. Achlorhydria reduces the absorption of calcium carbonate. In theory, proton pump inhibitors might impair calcium absorption, but evidence is lacking. It may be preferable for patients taking proton pump inhibitors to take calcium supplements with meals and perhaps to take calcium in the form of calcium citrate.
Adverse effects
Calcium supplements are usually well tolerated. Occasional adverse effects include constipation, bloating and flatulence. Changing preparations (for example, from calcium carbonate to calcium citrate) may alleviate these adverse effects. Calcium supplementation is contraindicated in the presence of hypercalcaemia or marked hypercalciuria, and during calcitriol therapy for osteoporosis, because of the risk of inducing hypercalcaemia or hypercalciuria. Measurement of the serum calcium, albumin and creatinine should therefore be part of the pre-treatment evaluation of patients presenting with apparent osteoporosis. Caution is also required in renal impairment, sarcoidosis and when there is a history of nephrolithiasis.